Amaryl
The General Glimepiride and 4-mg. The Tablets (Amaryl) and New and 8-mg. Doses for Diabetes
Approved new general wordings glimepiride. tablets (made Dr. Reddy’s Laboratories, Ltd., Pharmaceuticalses Invagen, Inc., CorePharma, LLC, Pharmaceuticalses Teva USA, and Ranbaxy Laboratories, Ltd; the name of the mark Amaryl, was made Aventis Pharmaceuticals, Inc.).
New power of the dose glimepiride 3, 6, and 8-mg. tablet (made Ranbaxy Laboratories, Ltd.), were also approved as the general wordings.
The Tablets Glimepiride is specified for governing hyperglycemia on patient with types 1 and 2 diabeteses mellitus.
The Note Editor: Ortho-McNeil Neurologics, Inc., declared in April 11, 2005 that their name of the mark Reminyl (galantamine hydrobromide), must be changed on Razadyne in response to messages assigning and distributing mistakes because of bewilderment of the names Reminyl and medicine of the diabetes Amaryl (glimepiride), which marketed Sanofi-Aventis.
The Octet 26, 2004 USA. Food and Administration Medicine, Products Janssen Pharmaceutica, LP, and Johnson & Pharmaceutical DEVELOPMENTS Johnson, LLC, have warned the pharmacist, and other healthcare professional through letter of the messages error medication, including bewilderment between galantamine hydrobromide (Reminyl, made Janssen/J&J) and glimepiride (Amaryl, made by Pharmaceuticalses Aventis, Inc.), according to safe alert sent from MedWatch today, safe information and disadvantage event, reporting program.
The Errors medication included the examples glimepiride substitutions for given galantamine. Wrong to distribute and administration glimepiride organized to different patient disadvantage event, including serious hypoglycemia and one death.
Galantamine is Specified on processing soft to soften Alzheimer’s-insanity of the type, and glimepiride is specified on processing non insulin- hung type 2 diabeteses mellitus.
According to letter, the prescriptions is wrong written, are interpreted, labeled, and/or filled because of resemblance of the name of the mark, overlaying power of the dose (4 mg.) and the forms (the tablet), and the general name, which can conduct to their of the memories.
Emphasizes the differences between galantamine and glimepiride with standpoint initial dosing (4 mg. twice daily against 2 mg. as soon as daily), available power of the tablet, and appearances of the tablet.
Galantamine Available in round tablet (4 mg., whitish; 8 mg., rose; 12 mg., orange-brown) printed “Janssen” on one side, and G accompanied by power of the dosage on another. Glimepiride Available in external flat tablet (1 mg., rose; 2 mg., green; 4 mg., blue) printed “Amaryl” and have a notched sides in amount.
